FivePrime Therapeutics is Drug Discovery in United States that focus on Prime Therapeutics Inc business. Founded in 2001. They cover business area such as five Prime Therapeutics Inc, protein therapeutic, disease, patient population, therapy, its internal pipeline, retain right, product, target specialty market, additional collaboration, its internal development capability, these collaboration, additional funding, order, Bemarituzumab.
2001
( 23 years old in 2024 )
Prime Therapeutics Inc
-
111 Oyster Point Boulevard
South San Francisco, CA 94080
United States
Private
five Prime Therapeutics Incprotein therapeuticdiseasepatient populationtherapyits internal pipelineretain rightproducttarget specialty marketadditional collaborationits internal development capabilitythese collaborationadditional fundingorderBemarituzumab
* We use standard office opening hours in near FivePrime Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
FivePrime Therapeutics is Drug Discovery business from United States that founded in 2001 (23 years old in 2024), FivePrime Therapeutics business is focusing on Prime Therapeutics Inc.
FivePrime Therapeutics headquarter office and corporate office address is located in 111 Oyster Point Boulevard South San Francisco, CA 94080 United States.
FivePrime Therapeutics was founded in United States.
In 2024, FivePrime Therapeutics is currently focus on Prime Therapeutics Inc sector.
Above is snippet of Google Trends for "Prime Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with FivePrime Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
